Position in TGTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$135,645,266
+$84,409,662 QoQ
Shares Held
2,468,971
+60.1% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#11
of 426 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Derivatives in TGTX
reported options exposure · as of Jun 30, 2026CallValue
$802,124
CallShares
14,600
PutValue
$1,280,102
PutShares
23,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. TGTX ranks #14 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in TGTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $802,124 | 14,600 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $135,645,266 | 2,468,971 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,280,102 | 23,300 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $51,235,604 | 1,542,312 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,611,954 | 1,060,448 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,146,553 | 889,870 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,087,314 | 613,707 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,293,185 | 793,639 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,246,860 | 606,208 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,860,295 | 1,062,860 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,214,467 | 1,361,128 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,013,584 | 263,878 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,643,984 | 154,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,573,719 | 2,341,354 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,516,368 | 1,832,382 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,347,841 | 1,352,915 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,983,766 | 1,012,998 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,906,047 | 1,166,562 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,155,402 | 1,448,330 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,853,082 | 825,771 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $5,708,711 | 118,438 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,116,238 | 232,915 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $4,445,160 | 228,191 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||